menu
    • menu

    Company profile for Jubilant Cadista Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Jubilant Cadista is a rapidly growing generic pharmaceutical company in the United States providing new and advanced products Cadista Holdings Inc and its fully owned subsidiary Jubilant Cadista Pharmaceuticals, Inc, is a Jubilant Life Sciences Company based in Noida, India are devoted to discovery, manufacture, sale and distribution of prescription generic pharmaceutical products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jubilant Cadista PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    207, Kiley Drive, Salisbury, Maryland-21801, USA
    Telephone
    Telephone
    +1 410 860 8500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cadista.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jubilant Pharmova to close Mfg Solid dosage facility of Jubilant Cadista USA
    Jubilant Pharmova to close Mfg Solid dosage facility of Jubilant Cadista USA

    19 Apr 2024

    // INDINPHARMAPOST

    https://www.indianpharmapost.com/news/jubilant-pharmova-to-close-manufacturing-operations-of-solid-dosage-formulation-facility-of-jubilant-cadista-usa-15540

    INDINPHARMAPOST
    19 Apr 2024
    Share Share
    Jubilant's Generic Loperamide Hydrochloride Receives Approval in the U.S.
    Jubilant's Generic Loperamide Hydrochloride Receives Approval in the U.S.

    05 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217840

    FDA
    05 Jul 2023
    Share Share
    Enforcement Report - Week of January 11, 2023
    Enforcement Report - Week of January 11, 2023

    11 Jan 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-11-2023-52259.pdf

    FDA
    11 Jan 2023
    Share Share
    Manufacturing issues led drug to recall products in US
    Manufacturing issues led drug to recall products in US

    14 Aug 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-makers-glenmark-sun-pharma-dr-reddys-to-recall-products-in-us-due-to-manufacturing-issues/articleshow/93552988.cms

    ECONOMIC TIMES
    14 Aug 2022
    Share Share
    Enforcement Report - Week of August 3, 2022
    Enforcement Report - Week of August 3, 2022

    03 Aug 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-3-2022-1659944441.pdf

    FDA
    03 Aug 2022
    Share Share
    Enforcement Report - Week of April 13, 2022
    Enforcement Report - Week of April 13, 2022

    13 Apr 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-13-2022-1649826529.pdf

    FDA
    13 Apr 2022
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search